Skip to main content

Table 1 Rare variants in patients with unilateral high myopia

From: Clinical and genetic risk factors underlying severe consequence identified in 75 families with unilateral high myopia

Variants

Family

Gene

(ReIseqID)

Nucleotide acid

Amino acid

REVEL

CADD

â‘ 

â‘¡

â‘¢

â‘£

⑤

HSF

ACMG-AMP

ID

Change

Effect

        

Criteria

A. Pathogenic variants

 

 1

F13-II:2

TSPAN12

(NM_012338.3)

c.375G > A

p.Trp125*

/

/

/

/

/

/

DM

/

PVS1;PS1;PM2;PM4;PM6;PP4

 2

F15-II:2

ZEB2

(NM_014795.4)

c.298_300del

p.Asn100del

/

/

/

/

/

/

DM

NSSC

PS1;PS2;PM2;PM4;PM6

 3

F14-II:1

GPR179

(NM_001004334.4)

c.3238C > T

p.Gln1080*

/

/

/

/

/

17/280534

DM?

/

PVS1; PM3;PM4; PP1

 4

F14-II:1

GPR179

(NM_001004334.4)

c.3656_3657del

p.Pro1219Argfs*18

/

/

/

/

/

51/280988

DM?

/

PVS1;PM3;PP1

 5

F18-II:1

OPN1LW

(NM_020061.6)

LLIAVA

/

/

/

/

/

/

/

DM

SSC

PVS1;PS1;PS2; PS3;PM2;PP1

 6

F19-II:1

FRMD7

(NM_194277.2)

c.910C > T

p.Arg304*

/

/

/

/

/

1/183050

DM

/

PVS1;PS1;PM2;PM4;PP1;PP4

B. Likely pathogenic variants

 

 1

F2-II:2

COL2A1

(NM_001844.4)

c.943G > A

p.Gly315Ser

0.97

28.8

D

PD

D

/

/

SSC

PM5;PM2;PP1;PP3

 2

F3-II:2

COL11A1

(NM_001854.4)

c.2971G > A

p.Gly991Ser

0.982

31

D

PD

D

/

/

SSC

PM5;PM2;PP1;PP3;PP4

 3

F7-II:2

FBN1

(NM_000138.4)

c.4894C > T

p.Arg1632Cys

0.602

32

D

PD

D

1/251312

/

NSSC

PS2;PM5;PM2;PP3

 4

F9-II:1

FZD4

(NM_012193.3)

c.328_330del

p.Ile110del

/

/

/

/

/

/

/

SSC

PM4;PM2;PP1;PP3;PP4

 5

F10-II:1

FZD4

(NM_012193.3)

c.313A > G

p.Met105Val

0.511

24.9

T

PD

N

6/250246

DM

SSC

PS1;PP1;PP3;PP4

 6

F11-II:1

LRP5

(NM_002335.3)

c.4466C > A

p.Thr1489Lys

0.751

26.7

D

PB

D

/

/

SSC

PM5;PM2;PP1;PP3;PP4

C. Uncertain significance variants

 

 1

F1-II:1

COL2A1

(NM_001844.4)

c.86-35G > A

/

/

/

/

/

/

/

/

SSC

PM2;PP1;PP3;PP4

 2

F4-II:1

COL11A1

(NM_001854.4)

c.1899 + 3A > G

/

/

/

/

/

/

/

/

SSC

PM6;PP3;PP4

 3

F5-II:2

COL11A1

(NM_001854.4)

c.1630G > T

p.Gly544Trp

0.95

33

D

PD

D

/

/

NSSC

PM2;PP1;PP3

 4

F6-II:2

COL11A1

(NM_001854.4)

c.2502 + 11G > T

/

/

/

/

/

/

/

/

NSSC

PM2;PP1

 5

F8-II:1

FBN1

(NM_000138.4)

c.7841C > T

p.Ala2614Val

0.434

23.2

T

PD

N

/

/

NSSC

PM2;PP1

 6

F12-II:2

LRP5

(NM_002335.3)

c.4505C > T

p.Pro1502Leu

0.743

29.4

D

PD

D

/

/

NSSC

PM2;PP1;PP3;PP4

 7

F16-II:2

PAX6

(NM_000280.5)

c.652A > G

p.Thr218Ala

0.906

23.5

D

PD

D

/

/

NSSC

PM2;PP1;PP3;PP4

 8

F17-II:1

GPR143

(NM_000273.2)

c.767 + 10C > G

/

/

/

/

/

/

/

/

NSSC

PM2;PP4

 9

F20-II:2

CACNA1F

(NM_005183.4)

c.1969G > A

p.Ala657Thr

0.749

24.5

D

PB

D

12/168126

/

NSSC

PM2: PP1; PP3

  1. For COL11A1 in gnomAD, 5% variants had REVEL or CADD scores greater than 0.867 or 32, while 75% had such scores less than 0.657 or 27.2. For COL2A1 in gnomAD, 5% variants had REVEL or CADD scores greater than 0.600 or 29.6, while 75% had such scores less than 0.311 or 27.4. For LRP5 in gnomAD, 5% variants had REVEL or CADD scores greater than 0.940 or 31, while 75% had such scores less than 0.740 or 25.1. For FZD4 in gnomAD, 5% variants had REVEL or CADD scores greater than 0.787 or 28.6, while 75% had such scores less than 0.613 or 24.2. For FBN1 in gnomAD, 5% variants had REVEL or CADD scores greater than 0.863 or 29, while 75% had such scores less than 0.665 or 25.6. For CACNA1F in gnomAD, 5% variants had REVEL or CADD scores greater than 0.909 or 26.8, while 75% had such scores less than 0.845 or 25.9. For PAX6 in gnomAD, 5% variants had REVEL or CADD scores greater than 0.880 or 29.9, while 75% had such scores less than 0.610 or 24.8
  2. PD Probably damaging, PB Possibly damaging, D Damaging, B Benign, T Tolerant, N Neutral, DM Damaging mutation, / Not available, SSC Splicing sites changes, NSSC No significant impact on splicing site. â‘  SIFT, â‘¡ Polyphen-2, â‘¢ PROVEAN, â‘£ GnomAD allele frequency, â‘¤ HGMD database